You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenovirus serotype 26

Showing 1 - 25 of 2,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19 Trial in Maputo (BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell), Ad26.COV2.S (Recombinant,

Recruiting
  • Covid19
  • BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)
  • +2 more
  • Maputo, Mozambique
    Centro de Investigação e Treino em Saúde da Polana Caniço - Inst
Mar 31, 2022

Healthy Trial in Mount Pleasant (Ad26.RSV.preF, Fluarix, Placebo)

Completed
Has Results
  • Healthy
  • Ad26.RSV.preF
  • +2 more
  • Mount Pleasant, South Carolina
    Coastal Carolina Research Center
Jul 22, 2021

Healthy Trial in United States (RSV Vaccine, Placebo)

Completed
  • Healthy
  • RSV Vaccine
  • Placebo
  • San Diego, California
  • +8 more
Sep 23, 2021

Healthy Trial in Fukuoka (RSV Vaccine, Placebo)

Completed
  • Healthy
  • RSV Vaccine
  • Placebo
  • Fukuoka, Japan
    Souseikai Hakata Clinic
Feb 16, 2021

Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)

Terminated
Has Results
  • Human Papillomavirus Infections
  • Ad26.HPV16
  • +3 more
  • Doral, Florida
  • +11 more
Nov 23, 2021

Respiratory Syncytial Virus Prevention Trial in Japan (Ad26/protein preF RSV Vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Prevention
  • Ad26/protein preF RSV Vaccine
  • Placebo
  • Akashi-shi, Japan
  • +29 more
Aug 2, 2022

Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)

Completed
  • Respiratory Syncytial Virus
  • Ad26.RSV.preF
  • +2 more
  • Geelong, Australia
  • +24 more
Nov 23, 2021

Comparative Evaluation of Covid-19 Vaccines Response

Recruiting
  • COVID-19 Vaccines
  • Covid-19 Inactive Vaccine, recombinant human adenovirus serotype number 26, mRNA VAccine
  • Karaman, Turkey
  • +3 more
Jul 11, 2021

Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

Active, not recruiting
  • Healthy
  • Ad26.Mos4.HIV
  • +2 more
  • Birmingham, Alabama
  • +52 more
Jan 17, 2023

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Healthy Trial in Merksem (Ad26.RSV.preF)

Completed
  • Healthy
  • Ad26.RSV.preF
  • Merksem, Belgium
    Clinical Pharmacology Unit
Aug 29, 2019

Cocaine Dependence Trial in New York (dAd5GNE Vaccine, Placebo)

Recruiting
  • Cocaine Dependence
  • dAd5GNE Vaccine
  • Placebo
  • New York, New York
    WCMC Department of Genetic Medicine
Mar 29, 2022

HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

Completed
  • HIV Infections
  • MRKAd5 HIV-1 gag/pol/nef
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

Completed
  • Human Immunodeficiency Virus
  • Ad26.Mos4.HIV
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 7, 2022

Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

Completed
Has Results
  • Ebola Virus
  • cAd3-EBO S vaccine
  • Kampala, Uganda
    Makerere University-Walter Reed Project
Nov 10, 2022

Respiratory Syncytial Viruses, Lower Respiratory Tract Disease Trial in Worldwide (Adenovirus serotype 26 (Ad26)-based

Recruiting
  • Respiratory Syncytial Viruses
  • Lower Respiratory Tract Disease
  • Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF
  • Placebo
  • Birmingham, Alabama
  • +341 more
Aug 2, 2022

Marburg Virus Disease Trial in Silver Spring (cAd3-Marburg vaccine)

Completed
Has Results
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Silver Spring, Maryland
    WRAIR Clinical Trials Center,
Aug 9, 2022

Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Active, not recruiting
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • AAV2-hRPE65v2
  • (no location specified)
Dec 9, 2021

HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

Completed
  • HIV Infections
  • DNA Vaccine
  • +5 more
  • Birmingham, Alabama
  • +9 more
Oct 13, 2021

Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

Recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Stockholm, Sweden
  • +1 more
Apr 4, 2022

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Virus Diseases, Hemorrhagic Fever, Ebola, Infections Trial in Kambia (Ad26.ZEBOV, MVA-BN-Filo)

Recruiting
  • Virus Diseases
  • +10 more
  • Ad26.ZEBOV, MVA-BN-Filo
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Oct 11, 2022

Respiratory Syncytial Virus Prevention Trial in United States (Ad26.RSV.preF-based vaccine)

Completed
  • Respiratory Syncytial Virus Prevention
  • Ad26.RSV.preF-based vaccine
  • San Diego, California
  • +8 more
Oct 25, 2022

Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Feb 25, 2022

COVID-19 Trial in Al Ain (AZD1222, rAd26-S)

Completed
  • COVID-19
  • AZD1222
  • rAd26-S
  • Al Ain, United Arab Emirates
    Tawam Hospital
Oct 24, 2022